Lypd3 | Ly6/Plaur domain containing 3
Physiological systems
17 / 24 physiological systems tested
3 Significantly impacted by the knock-out
Homeostasis/metabolism Behavior/neurological Mortality/aging
14 No significant impact
7 Not tested
Data collections
Gene metrics:4Significant phenotypes
0Associated diseases
Expression examined in:46Adult tissues
0Embryo tissues
increased circulating triglyceride level | 1 supporting dataset | Lypd3tm1.1(KOMP)Vlcg | heterozygote | Early adult | 7.95x10-10 | ||
increased food intake | 1 supporting dataset | Lypd3tm1.1(KOMP)Vlcg | heterozygote | Early adult | 1.49x10-7 | ||
preweaning lethality, incomplete penetrance | 3 supporting datasets | Lypd3tm1.1(KOMP)Vlcg | homozygote | Early adult | N/A * | ||
increased blood urea nitrogen level | 1 supporting dataset | Lypd3tm1.1(KOMP)Vlcg | heterozygote | Early adult | 3.15x10-5 |
| | | | | | | | | |
External links
No external links available for Lypd3.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
Lypd3tm1(KOMP)Vlcg | Reporter-tagged deletion allele (with selection cassette) | | ES Cell mouse |
Lypd3tm1.1(KOMP)Vlcg | Reporter-tagged deletion allele (post Cre, with no selection cassette) | | mouse |
Lypd3tm1a(EUCOMM)Hmgu | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector ES Cell |
Lypd3tm1e(EUCOMM)Hmgu | Targeted, non-conditional allele | | ES Cell |